Co-Marketing Agreement for Microarray Solutions
Complete the form below to unlock access to ALL audio articles.
PerkinElmer, Inc. and Eppendorf AG have announced the signing of a co-marketing agreement to jointly promote microarray technology that combines Eppendorf’s DualChip™ content arrays with PerkinElmer’s ScanArray™ GX Microarray Analysis System.
The announcement was made at the Chips to Hits industry event being held September 12-14, 2005, in Boston.
The combination of the DualChip technology, consisting of 2 identical arrays on a single slide, and the scanning protocols of ScanArray GX designed to provide a complete solution, from array processing to data analysis.
PerkinElmer claims that, the PerkinElmer/Eppendorf microarray solution is ideal for a wide range of applications, including medical, clinical and biotechnology research.
“Our scanners, combined with the optimized protocols for Eppendorf’s new chip technologies, will deliver reliability and simplicity to customers,” said Peter Coggins, PhD., president, PerkinElmer Life and Analytical Sciences.
“For each DualChip, Eppendorf will provide exact protocols to allow customers to set-up and optimize their assays on PerkinElmer scanners, thereby offering considerable advantages and significantly increasing efficiency.”
“With PerkinElmer and Eppendorf’s combined array expertise, committed scientists can now use an array as a personal tool that fits the budget,” stated Dr. Thomas Kolzau, director of the Microarray Systems Product Group at Eppendorf AG.
Only recently Eppendorf AG had been conferred the 2005 Frost & Sullivan Technology Innovation Award in recognition for its contribution by proactively leveraging its DualChip Microarray technology to molecular technologies towards possible drug discovery and clinical research applications.
According to Frost & Sullivan’s findings, microarrays have been widely demonstrated to empower researchers working in drug discovery and clinical research through the _expression profiling method.
